| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148440C Feed product |
| 05/05/2004 | CN1148228C Gene medicine for treating hemophilia B and its preparing process |
| 05/05/2004 | CN1148223C Enopeptin containing compound preparation and its medical use for controlling sutaneous pigmentation |
| 05/05/2004 | CN1148222C Traditional Chinese medicine prepn. for treating acute and chronic bronchitis, and its prepn. method |
| 05/05/2004 | CN1148221C Chinese-medicinal antihypertensive pillow |
| 05/05/2004 | CN1148220C Antivirus antipyretic |
| 05/05/2004 | CN1148218C Wind dispelling and cold expelling snake ointment |
| 05/05/2004 | CN1148216C Medicine for curing acne and sore |
| 05/05/2004 | CN1148215C Kidney benefiting belt |
| 05/05/2004 | CN1148211C Medicine for treating congestive heart failure |
| 05/05/2004 | CN1148210C Exterior-applied Chinese-medicinal plaster for treating bone tuberculosis |
| 05/05/2004 | CN1148204C Chinese medicine preparation for treating mastoplasia and its preparing process |
| 05/05/2004 | CN1148202C Preparation for eliminating bursa |
| 05/05/2004 | CN1148196C Buccal red deer horn tablet |
| 05/04/2004 | US6730504 Bacillus natto culture extract |
| 05/04/2004 | US6730502 Fructosyltransferases |
| 05/04/2004 | US6730315 Medium and matrix for long-term proliferation of cells |
| 05/04/2004 | US6730314 Culturing encapsulated chondrocytes under reduced oxygen partial pressure to produce cartilage implants |
| 05/04/2004 | US6730307 Monoclonal antibody |
| 05/04/2004 | US6730303 Fused G-CSF and IL-3 proteins and uses thereof |
| 05/04/2004 | US6730298 Tissue formation by injecting a cell-polymeric solution that gels in vivo |
| 05/04/2004 | US6730016 Cardiac disease treatment and device |
| 04/29/2004 | WO2004035787A2 Transplantable cell with immune modulator |
| 04/29/2004 | WO2004035779A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/29/2004 | WO2004035616A2 Adenovirus expressing genes in reverse order and use thereof |
| 04/29/2004 | WO2004035072A2 Identifying and treating vaginal infections |
| 04/29/2004 | WO2004035069A1 Pharmaceutical antidiabetic composition |
| 04/29/2004 | WO2004035068A1 Use of enteric glia to promote functional nerve connections |
| 04/29/2004 | WO2004035067A1 Method for extracting a natural mixture of conjugated equine estrogens that is depleted of non-conjugated lipophilic compounds |
| 04/29/2004 | WO2004035066A1 Plasma preparation or serum preparation and process for producing the same |
| 04/29/2004 | WO2004035011A2 Botulinum toxin dental therapies and procedures |
| 04/29/2004 | WO2004034989A2 Probiotic bacteria |
| 04/29/2004 | WO2004034984A2 Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
| 04/29/2004 | WO2004034808A1 Method of improving immune function in mammals using lactobacillus reuteri strains |
| 04/29/2004 | WO2004034789A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 04/29/2004 | WO2004013275A3 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2003104485A3 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 04/29/2004 | WO2003064601A8 Adult human olfactory stem cell |
| 04/29/2004 | WO2003061675A8 Biologically active additive to food and method for producing said additive |
| 04/29/2004 | WO2003054170A8 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/29/2004 | WO2003015612A9 Materials and methods to promote repair of nerve tissue |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2002070748A3 Response of dendritic cells to a diverse set of pathogens |
| 04/29/2004 | WO2002043651A8 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 04/29/2004 | WO2002043649A8 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 04/29/2004 | WO2001003515A8 Method of obtaining protein isolates and concentrates from colostrum |
| 04/29/2004 | US20040082934 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 04/29/2004 | US20040082539 Extracting naturally occurring carbohydrate glucan from microorganisms; use in treatment of skin ulceration or bone fracture or enhancement of fixation of implanted orthopaedic devices, prevention/treatment of ultraviolet light skin damage |
| 04/29/2004 | US20040082538 Adjuvants and processes to induce a specific type of immune response |
| 04/29/2004 | US20040082529 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 04/29/2004 | US20040082511 Drug composition for the promotion of tissue regeneration |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082065 Cascading priming cells; stimulating lymphocytes; incubation |
| 04/29/2004 | US20040082064 Stimulanting immunology response; calibrating success of organ, tissue transplant; polymerase chain reaction analysis; administering immunosuppressants |
| 04/29/2004 | US20040082063 Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
| 04/29/2004 | US20040082054 Novel depsipeptide compound |
| 04/29/2004 | US20040082012 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081955 Animal extract from earthworm; contraceptive; side effect reduction |
| 04/29/2004 | US20040081714 Cosmetic and/or pharmaceutical preparations |
| 04/29/2004 | US20040081703 Sharks are a potential source of matrix metalloproteinase inhibitor angiogenesis inhibitor because their endoskeleton is composed entirely of cartilage |
| 04/29/2004 | US20040081702 Standardized bee venom preparation suitable for administration by injection comprising |
| 04/29/2004 | US20040081673 Compositions and methods for the treatment of skin damage |
| 04/29/2004 | US20040081667 Compositions and methods for treating and preventing infection |
| 04/29/2004 | US20040081658 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | US20040081636 Genetic engineering; polynucleotides |
| 04/29/2004 | CA2515650A1 New adenoviruses, nucleic acids coding therefor and their use |
| 04/29/2004 | CA2510355A1 Use of enteric glia to promote functional nerve connections |
| 04/29/2004 | CA2502312A1 Transplantable cell with immune modulator |
| 04/29/2004 | CA2502221A1 Plasma preparation or serum preparation and process for producing the same |
| 04/29/2004 | CA2501856A1 Botulinum toxin dental therapies and procedures |
| 04/29/2004 | CA2498095A1 Method for extracting a natural mixture of conjugated equine estrogens that is depleted of non-conjugated lipophilic compounds |
| 04/29/2004 | CA2497313A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/28/2004 | EP1413614A1 Method for producing fish gelatin peptide |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412486A2 Method for virus propagation |
| 04/28/2004 | EP1412485A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/28/2004 | EP1412484A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 04/28/2004 | EP1412483A1 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications |
| 04/28/2004 | EP1412479A2 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1412001A2 Photolytic cell for providing physiological gas exchange |
| 04/28/2004 | EP1411994A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 04/28/2004 | EP1411989A2 Methods for improving cell line activity in immunoisolation devices |
| 04/28/2004 | EP1411979A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/28/2004 | EP1411974A2 Materials and methods relating to improved vaccination strategies |
| 04/28/2004 | EP1411971A1 Use of long pentraxin ptx3 for treating female infertility |
| 04/28/2004 | EP1411970A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/28/2004 | EP1411969A1 Modified protamine with reduced immunogenicity |
| 04/28/2004 | EP1411963A2 Cytotoxic factors for modulating cell death |
| 04/28/2004 | EP1411957A1 Treatment of muscular distrophy with cord blood cells |
| 04/28/2004 | EP1411953A1 Methods and compositions for treatment of gastric diseases |
| 04/28/2004 | EP1411880A2 Recombinant vsv for the treatment of tumor cells |
| 04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 04/28/2004 | EP1255559B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/28/2004 | EP1084232B1 Genetically-modified fibroblasts and the use thereof |